Strategies for Managing Patients With Melanoma
Marc S. Ernstoff, MD, provides recommendations for managing patients with metastatic melanoma.
Rationale for Immunotherapy in Melanoma Regardless of BRAF Status
Marc S. Ernstoff, MD, discusses why physicians would treat metastatic melanoma with immunotherapy prior to small molecule inhibitors in most cases.
Understanding the Current Era of Metastatic Melanoma
Marc S. Ernstoff, MD, discusses metastatic melanoma and how patients may be managed.
PFS and Safety With Nivolumab Plus Ipilimumab in Advanced Melanoma
Marc Ernstoff, MD, director of melanoma, Cleveland Clinic, discusses progression-free survival (PFS) and safety in patients with advanced melanoma (MEL) receiving nivolumab (NIVO) combined with ipilimumab (IPI).
2 Commerce Drive Cranbury, NJ 08512